Evidence map›Paper›PMID 30737131›Full record

ArticleNeuron2019

Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer's Disease Model.

Mario Merlini, Victoria A Rafalski, Pamela E Rios Coronado, T Michael Gill, Maya Ellisman, Gayathri Muthukumar, Keshav S Subramanian, Jae Kyu Ryu, Catriona A Syme, Dimitrios Davalos and 4 more

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Neuron, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 267 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
267citing papers in PubMed, 1 pooled it
20.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

267 citing papers in PubMed, 1 synthesis or guideline pooled it, 426 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. CSF fibrinogen predicts longitudinal Tau accumulation in cognitively unimpaired older adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

207 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Mario MerliniGladstone Institute of Neurological Disease, San Francisco, CA 94158, USA.
Victoria A RafalskiGladstone Institute of Neurological Disease, San Francisco, CA 94158, USA.
Pamela E Rios CoronadoGladstone Institute of Neurological Disease, San Francisco, CA 94158, USA.
T Michael GillGladstone Institute of Neurological Disease, San Francisco, CA 94158, USA.
Maya EllismanGladstone Institute of Neurological Disease, San Francisco, CA 94158, USA.
Gayathri MuthukumarGladstone Institute of Neurological Disease, San Francisco, CA 94158, USA.
Keshav S SubramanianGladstone Institute of Neurological Disease, San Francisco, CA 94158, USA.
Jae Kyu RyuGladstone Institute of Neurological Disease, San Francisco, CA 94158, USA.
Catriona A SymeGladstone Institute of Neurological Disease, San Francisco, CA 94158, USA.
Dimitrios DavalosGladstone Institute of Neurological Disease, San Francisco, CA 94158, USA.
William W SeeleyDepartment of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.
Lennart MuckeGladstone Institute of Neurological Disease, San Francisco, CA 94158, USA; Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.
Robert B NelsonLundbeck Research USA, Paramus, NJ 07652, USA.
Katerina AkassoglouGladstone Institute of Neurological Disease, San Francisco, CA 94158, USA; Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA. Electronic address: kakassoglou@gladstone.ucsf.edu.
Gladstone Institutes · USLundbeck (United States) · USUniversity of California, San Francisco · US

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MILLER, BRUCE L · 2004 to 2018
$27.1M
IVEM and Image Analysis ResourceP41GM103412 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELLISMAN, MARK H · 2012 to 2019
$17.9M
Neurovascular Interactions: Mechanisms, imaging, therapeutic potentialR35NS097976 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI AKASSOGLOU, KATERINA · 2016 to 2023
$11.1M
MOLECULAR AND CELLULAR IMMUNOLOGYT32AI007334 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CYSTER, JASON G · 1988 to 2023
$11.0M
Mechanisms of Fibrin Action in Neuronal FunctionsR21NS082976 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI AKASSOGLOU, KATERINA · 2014 to 2015
$525k
Role of Fibrinogen in Neuronal DysfunctionF32NS096920 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI RAFALSKI, VICTORIA · 2017 to 2018
$126k
NIAID NIH HHS T32 AI007334NIA NIH HHS P01 AG019724NIA NIH HHS P50 AG023501NIGMS NIH HHS P41 GM103412NINDS NIH HHS F32 NS096920NINDS NIH HHS R21 NS082976NINDS NIH HHS R35 NS097976
6 · The paper itself

Abstract

Cerebrovascular alterations are a key feature of Alzheimer's disease (AD) pathogenesis. However, whether vascular damage contributes to synaptic dysfunction and how it synergizes with amyloid pathology to cause neuroinflammation and cognitive decline remain poorly understood. Here, we show that the blood protein fibrinogen induces spine elimination and promotes cognitive deficits mediated by CD11b-CD18 microglia activation. 3D molecular labeling in cleared mouse and human AD brains combined with repetitive in vivo two-photon imaging showed focal fibrinogen deposits associated with loss of dendritic spines independent of amyloid plaques. Fibrinogen-induced spine elimination was prevented by inhibiting reactive oxygen species (ROS) generation or genetic ablation of CD11b. Genetic elimination of the fibrinogen binding motif to CD11b reduced neuroinflammation, synaptic deficits, and cognitive decline in the 5XFAD mouse model of AD. Thus, fibrinogen-induced spine elimination and cognitive decline via CD11b link cerebrovascular damage with immune-mediated neurodegeneration and may have important implications in AD and related conditions.

Indexed as

Alzheimer DiseaseAnimalsBlood-Brain BarrierBrainCD11b AntigenCD18 AntigensCognitive DysfunctionDendritic SpinesDisease Models, AnimalFibrinogenHumansImaging, Three-DimensionalMiceMicrogliaPlaque, AmyloidReactive Oxygen SpeciesCD11b AntigenCD18 AntigensFibrinogenReactive Oxygen Speciesblood-brain barriercoagulationcomplementdementiadendritic spinesfibriniDISCOinnate immunitymultiple sclerosisneurovascular

Identifiers

PMID30737131
PMCPMC6602536
OpenAlexW2913141969

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.